Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - Ra Medical Systems, Inc. | d625972dex231.htm |
S-1MEF - S-1MEF - Ra Medical Systems, Inc. | d625972ds1mef.htm |
Exhibit 5.1
September 26, 2018
Ra Medical Systems, Inc.
2070 Las Palmas Drive
Carlsbad, California
Re: Registration Statement on Form S-1 (File No. 333-226191) and Registration Statement filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended (the Securities Act)
Ladies and Gentlemen:
This opinion is furnished to you in connection with the Registration Statement on Form S-1 (the Registration Statement), filed by Ra Medical Systems, Inc. (the Company) with the Securities and Exchange Commission pursuant to Rule 462(b) of the Securities Act of 1933, as amended (the Securities Act) in connection with the registration under the Securities Act of 651,668 shares (including 85,001 shares issuable upon exercise of an option to purchase additional shares granted to the underwriters) of the Companys common stock, par value $0.0001 per share (the Shares), to be issued and sold by the Company. The Registration Statement incorporates by reference the Registration Statement on Form S-1 (No. 333-226191) (the Prior Registration Statement), which was declared effective on September 26, 2018, including the prospectus which forms part of the Registration Statement. We understand that the Shares are to be sold by the Company to the underwriters for resale to the public as described in the Registration Statement and Prior Registration Statement and pursuant to an underwriting agreement, substantially in the form filed as an exhibit to the Prior Registration Statement, to be entered into by and among the Company and the underwriters (the Underwriting Agreement).
We are acting as counsel for the Company in connection with the sale of the Shares by the Company. In such capacity, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary for the purposes of rendering this opinion. In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity with the originals of all documents submitted to us as copies, the authenticity of the originals of such documents and the legal competence of all signatories to such documents.
We express no opinion herein as to the laws of any state or jurisdiction other than the General Corporation Law of the State of Delaware (including the statutory provisions and all applicable judicial decisions interpreting those laws) and the federal laws of the United States of America.
On the basis of the foregoing, we are of the opinion, that the Shares to be issued and sold by the Company have been duly authorized and, when such Shares are issued and paid for in accordance with the terms of the Underwriting Agreement, will be validly issued, fully paid and nonassessable.
Ra Medical Systems Inc.
September 26, 2018
Page 2
We consent to the use of this opinion as an exhibit to the Registration Statement, and we consent to the reference of our name under the caption Legal Matters in the prospectus forming part of the Prior Registration Statement, which is incorporated by reference into the Registration Statement.
Very truly yours, |
/s/ Wilson Sonsini Goodrich & Rosati, P.C. |
WILSON SONSINI GOODRICH & ROSATI |
Professional Corporation |